Direction de la Pharmacie, du Médicament et de la Médecine Traditionnelle — République d'Haïti
Haiti DPM/MT · Haiti · latin america
Haiti's pharmacy / medicine / traditional medicine directorate — leech-specific authorisation pathway not independently verified by ASH.
Regulatory Profile
- Agency type
- national regulator
- Region
- latin america
- Country
- Haiti
- Leech status
- unregulated
- Last ASH review
- 2026-05-28
- Website
- https://mspp.gouv.ht
Relevant Regulation Codes
- Haiti Décret Réglementant l'Exercice de la Pharmacie and amendments
- Caribbean Regulatory System (CRS) of CARPHA arrangements where applicable
Prescriber Requirements
- Haiti Association Médicale Haïtienne (AMH)–registered physician — order required for any biomedical device application
- Allied health professional application under physician supervision per institutional protocol
Supply Chain & GMP
Haiti DPM/MT registration as applicable; French and Haitian Kreyol-language labelling per local convention. Standard cold-chain conditions, with logistical constraints typical of Hispaniola distribution.
Import/Export Rules
Haiti DPM/MT and Direction de la Quarantaine Végétale et Animale du Ministère de l'Agriculture clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.
Reimbursement Context
Haiti's public health coverage is limited; hirudotherapy is generally not reimbursed; out-of-pocket payment predominates.
ASH Editorial Notes
Leech-specific authorisation pathway not independently verified by ASH; falls under general medical-device / Haitian traditional-medicine framework as appropriate. Haiti recognises traditional medicine (including herbal and folk practices) within its DPM/MT structure; whether this captures medicinal leech application has not been independently mapped by ASH.
Related Jurisdictions
ANVISA — Brazil
Brazil's national health-surveillance agency — leech therapy regulated as a medical device with parallel coverage under the SUS Practices Integrativas e Complementares (PICS) policy.
INVIMA — Colombia
Colombia's national medicines and devices surveillance agency — leech therapy regulated as a medical device under Decreto 4725/2005 with TM/CAM oversight by the Ministerio de Salud.
DIGEMID — Peru
Peru's medicines, supplies and drugs directorate — leech therapy supervised under Ley General de Salud and complementary-medicine framework, with DIRESA-level enforcement.
ANMAT — Argentina
Argentina's national administration of drugs, food and medical technology — leech-specific regulatory pathway has not been independently verified by ASH.